nach oben

Zeitschrift für Gerontologie und Geriatrie

Erschienen in:

01.01.2012 | Beiträge zum Themenschwerpunkt

Co-occurrence of parkinsonism and dementia in clinical practice

Relevant differential diagnoses

verfasst von: I. Liepelt-Scarfone, M. Jamour, W. Maetzler

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Co-occurrence of parkinsonism and dementia is commonly observed in the aging population. This narrative review gives an overview of disorders regularly presenting with these symptoms, e.g., idiopathic Parkinson disease with dementia, dementia with Lewy bodies, progressive supranuclear palsy, corticobasal degeneration syndrome, vascular cognitive impairment, drug-induced parkinsonism, and normal-pressure hydrocephalus. Both a thoroughly performed medical history and a comprehensive clinical examination can narrow down relevant differential diagnoses. Characteristic clinical and neuropsychological features are highlighted, including cognitive screening strategies. Neurophysiological and neuropathological aspects of the disorders are briefly discussed to give a better understanding of treatment options.

Vorheriger Artikel Diabetes und Demenz

Nächster Artikel Komorbidität von Depression und Demenz bei geriatrischen Patienten mit akuter körperlicher Erkrankung

Battistin L, Cagnin A (2010) Vascular cognitive disorder. A biological and clinical overview. Neurochem Res 35:1933–1938PubMedCrossRef

Bohnen NI, Kaufer DI, Hendrickson R et al (2006) Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and parkinsonian dementia. J Neurol 253:242–247PubMedCrossRef

Bronnick K, Emre M, Lane R et al (2007) Profile of cognitive impairment in dementia associated with Parkinson’s disease compared with Alzheimer’s disease. J Neurol Neurosurg Psychiatry 78:1064–1068PubMedCrossRef

Compta Y, Parkkinen L, O’Sullivan SS et al (2011) Lewy- and Alzheimer-type pathologies in Parkinson’s disease dementia: which is more important? Brain 134:1493–1505PubMedCrossRef

Cummings J, Litvan I (2000) Neuropsychiatric aspects of corticobasal degeneration. Adv Neurol 82:147–152PubMed

Elbaz A, Bower JH, Maraganore DM et al (2002) Risk tables for parkinsonism and Parkinson’s disease. J Clin Epidemiol 55:25–31PubMedCrossRef

Erkinjuntti T, Kurz A, Gauthier S et al (2002) Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: a randomised trial. Lancet 359:1283–1290PubMedCrossRef

Forsaa EB, Larsen JP, Wentzel-Larsen T et al (2010) What predicts mortality in Parkinson disease? A prospective population-based long-term study. Neurology 75:1270–1276PubMedCrossRef

Geser F, Wenning GK, Poewe W et al (2005) How to diagnose dementia with Lewy bodies: state of the art. Mov Disord 20(Suppl 12):11–20CrossRef

10.

Gilman S, Koeppe RA, Nan B et al (2010) Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes. Neurology 74:1416–1423PubMedCrossRef

11.

Grimes DA, Lang AE, Bergeron CB (1999) Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 53:1969–1974PubMed

12.

Hamilton R, Patel S, Lee EB et al (2010) Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology. Ann Neurol 68:535–540PubMedCrossRef

13.

Hardie RJ, Lees AJ (1988) Neuroleptic-induced Parkinson’s syndrome: clinical features and results of treatment with levodopa. J Neurol Neurosurg Psychiatry 51:850–854PubMedCrossRef

14.

Kehagia AA, Barker RA, Robbins TW (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease. Lancet Neurol 9:1200–1213PubMedCrossRef

15.

Kuo SH, Kenney C, Jankovic J (2008) Bilateral pedunculopontine nuclei strokes presenting as freezing of gait. Mov Disord 23:616–619PubMedCrossRef

16.

Liepelt I, Gaenslen A, Godau J et al (2010) Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: clinical observations as a basis for power calculations and safety analysis. Alzheimers Dement 6:70–74PubMedCrossRef

17.

Liepelt I, Maetzler W, Blaicher HP et al (2007) Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors. Dement Geriatr Cogn Disord 23:351–367PubMedCrossRef

18.

Liepelt I, Reimold M, Maetzler W et al (2009) Cortical hypometabolism assessed by a metabolic ratio in Parkinson’s disease primarily reflects cognitive deterioration-[(18)F]FDG-PET. Mov Disord 24:1504–1511PubMedCrossRef

19.

Lippa CF, Duda JE, Grossman M et al (2007) DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68:812–819PubMedCrossRef

20.

Litvan I, Phipps M, Pharr VL et al (2001) Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy. Neurology 57:467–473PubMed

21.

Maetzler W, Liepelt I, Berg D (2009) Progression of Parkinson’s disease in the clinical phase: potential markers. Lancet Neurol 8:1158–1171PubMedCrossRef

22.

Maetzler W, Liepelt I, Reimold M et al (2009) Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics. Neurobiol Dis 34:107–112PubMedCrossRef

23.

Maetzler W, Nagele T, Gasser T et al (2007) Acute parkinsonism with corresponding lesions in the basal ganglia after heroin abuse. Neurology 68:414CrossRef

24.

Maetzler W, Schmid B, Synofzik M et al (2010) The CST3 BB genotype and low cystatin C cerebrospinal fluid levels are associated with dementia in Lewy body disease. J Alzheimers Dis 19:937–942PubMed

25.

Maetzler W, Stoycheva V, Schmid B et al (2010) Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-beta42 levels in Lewy body disease. J Alzheimers Dis 22:933–938PubMed

26.

McKeith I, Mintzer J, Aarsland D et al (2004) Dementia with Lewy bodies. Lancet Neurol 3:19–28PubMedCrossRef

27.

McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology 65:1863–1872PubMedCrossRef

28.

Mummenthaler M (1987) Behebbare und vermeidbare Demenzen. Schweiz Med Wochenschr 117:964–967

29.

Nicolai S, Mirelman A, Herman T et al (2010) Improvement of balance after audio-biofeedback. A 6-week intervention study in patients with progressive supranuclear palsy. Z Gerontol Geriatr 43:224–228PubMedCrossRef

30.

O’Sullivan SS, Massey LA, Williams DR et al (2008) Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 131:1362–1372

31.

Ott A, Breteler MM, Van Harskamp F et al (1995) Prevalence of Alzheimer’s disease and vascular dementia: association with education. The Rotterdam study. Br Med J (Clin Res) 10:970–973CrossRef

32.

Pendlebury ST, Cuthbertson FC, Welch SJ et al (2010) Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke 41:1290–1293PubMedCrossRef

33.

Penn RD, Linninger A (2009) The physics of hydrocephalus. Pediatr Neurosurg 45:161–174PubMedCrossRef

34.

Saczynski JS, Sigurdsson S, Jonsdottir MK et al (2009) Cerebral infarcts and cognitive performance: importance of location and number of infarcts. Stroke 40:677–682PubMedCrossRef

35.

Schneider JA, Arvanitakis Z, Bang W et al (2007) Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69:2197–2204PubMedCrossRef

36.

Seijo-Martinez M, Castro Del Rio M, Rodriguez Alvarez J et al (2011) Prevalence of parkinsonism and Parkinson’s disease in the Arosa Island (Spain): a community-based door-to-door survey. J Neurol Sci 304:49–54PubMedCrossRef

37.

Shelley BP, Hodges JR, Kipps CM et al (2009) Is the pathology of corticobasal syndrome predictable in life? Mov Disord 24:1593–1599PubMedCrossRef

38.

Sinforiani E, Banchieri L, Zucchella C et al (2004) Cognitive rehabilitation in Parkinson’s disease. Arch Gerontol Geriatr 9(Suppl):387–391CrossRef

39.

Srulijes K, Mallien G, Bauer S et al (2011) In vivo comparison of Richardson’s syndrome and progressive supranuclear palsy-parkinsonism. J Neural Transm 118:1191–1197PubMedCrossRef

40.

Tarnaris A, Toma AK, Chapman MD et al (2011) Use of cerebrospinal fluid amyloid-beta and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus. J Neurosurg 115:145–150PubMedCrossRef

41.

Trenkwalder C, Schwarz J, Gebhard J et al (1995) Starnberg trial on epidemiology of Parkinsonism and hypertension in the elderly. Prevalence of Parkinson’s disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years. Arch Neurol 52:1017–1022PubMedCrossRef

42.

Turner ST, Fornage M, Jack CR et al (2009) Genomic susceptibility Loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibships. Arch Neurol 66:847–857PubMedCrossRef

43.

Villarejo A, Benito-Leon J, Trincado R et al (2011) Dementia-associated mortality at thirteen years in the NEDICES cohort study. J Alzheimers Dis (in press)

44.

Wenning GK, Litvan I, Tolosa E (2011) Milestones in atypical and secondary parkinsonisms. Mov Disord 26:1083–1095PubMedCrossRef

45.

Williams DR, Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 8:270–279PubMedCrossRef

Titel: Co-occurrence of parkinsonism and dementia in clinical practice
Relevant differential diagnoses
verfasst von: I. Liepelt-Scarfone
M. Jamour
W. Maetzler
Publikationsdatum: 01.01.2012
Verlag: Springer-Verlag
Erschienen in: Zeitschrift für Gerontologie und Geriatrie / Ausgabe 1/2012
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI: https://doi.org/10.1007/s00391-011-0261-7

Springerpflege

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2012

Komorbidität von Depression und Demenz bei geriatrischen Patienten mit akuter körperlicher Erkrankung

Mitteilungen der ÖGGG

Diabetes und Demenz

Demenz

Palliativversorgung von Menschen mit Demenz

A brief update on dementia prevention